Silence Therapeutics PLC (SLN)
NASDAQ: SLN · IEX Real-Time Price · USD
19.95
1.24 (6.63%)
At close: Jan 21, 2022 4:00 PM
19.58
-0.37 (-1.85%)
After-hours:Jan 21, 2022 4:00 PM EST
Income Statement (Annual)
Millions USD. Fiscal year is Jan - Dec.
| Year | 2020 | 2019 | 2018 |
|---|---|---|---|
| Revenue | 5.48 | 0.24 | 0 |
| Revenue Growth (YoY) | 2145.49% | - | - |
| Cost of Revenue | 3.76 | 0 | 0 |
| Gross Profit | 1.72 | 0.24 | 0 |
| Selling, General & Admin | 13.98 | 9.64 | 10.83 |
| Research & Development | 20.21 | 13.34 | 9.74 |
| Other Operating Expenses | 3.37 | 0 | -0.01 |
| Operating Expenses | 37.56 | 22.98 | 20.57 |
| Operating Income | -35.85 | -22.73 | -20.57 |
| Interest Expense / Income | 0.32 | 0.16 | 0 |
| Other Expense / Income | -0.13 | -0.03 | -0.04 |
| Pretax Income | -36.04 | -22.87 | -20.53 |
| Income Tax | -3.49 | -3.29 | -2.12 |
| Net Income | -32.55 | -19.58 | -18.41 |
| Net Income Common | -32.55 | -19.58 | -18.41 |
| Shares Outstanding (Basic) | 78 | 78 | - |
| EPS (Basic) | - | -0.78 | -0.78 |
| EPS (Diluted) | - | -0.78 | -0.78 |
| Free Cash Flow Per Share | -0.43 | 0.07 | - |
| Gross Margin | 31.34% | 100.00% | - |
| Operating Margin | -654.26% | -9317.21% | - |
| Profit Margin | -594.03% | -8025.41% | - |
| Free Cash Flow Margin | -205.95% | 704.10% | - |
| Effective Tax Rate | 9.69% | 14.38% | 10.30% |
| EBITDA | -35.24 | -22.26 | -20.15 |
| EBITDA Margin | -643.22% | -9120.90% | - |
| EBIT | -35.72 | -22.71 | -20.53 |
| EBIT Margin | -651.91% | -9306.15% | - |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).